L-Lysine HCL

CAS NO. :657-27-2 Executive Standard:CP2020 Packing Specification:25kg/drum

L-Lysine HCL

CAS NO. :657-27-2 Executive Standard:USP39 / USP43 / AJI97 / EP7 / EP10  Packing Specification:25kg/drum

L-Lysine HCL

CAS NO. :657-27-2 Executive Standard:USP24 / USP39 / USP43 / AJI97 / EP7 / EP10 / CP2020 Packing Specification:25kg/drum

L- Glutamic Acid

CAS NO. :56-86-0 Executive Standard:USP24 / USP39 / USP43 / AJI97 / EP7 / EP10 / CP2020 Packing Specification:25kg/drum

L- Glutamic Acid

CAS NO. :56-86-0 Executive Standard:USP39 / USP43 / AJI97 / EP7 / EP10 Packing Specification:25kg/drum

L- Glutamic Acid

CAS NO. :56-86-0 Executive Standard:CP2020 Packing Specification:25kg/drum

L- Glutamic Acid

CAS NO. :56-86-0 Executive Standard:USP39 / USP43 / AJI97 / EP7 / EP10 / CP2020 Packing Specification:25kg/drum

Inosine

Inosine, also known as inosine, inosine, etc., chemical formula C10H12N4O5, is a nucleoside compound composed of inosine and ribose. In de novo synthesis of purines, inosinic acid (IMP) can be used as a precursor for the synthesis of adenylic acid (AMP) and guanylic acid (GMP). It is suitable for leukopenia, thrombocytopenia, various heart diseases, acute and chronic hepatitis, liver cirrhosis, etc. caused by various reasons. In addition, it can still treat central retinitis, optic atrophy, etc.

Amino Acid

The company mainly produces isoleucine, valine, leucine, lysine acetate, BCAA, carbocisteine and other amino acid raw materials and their derivatives. The company's quality system is perfect, and it has successively passed the GMP certification, HACCP quality management system certification, KOSHER and HALAL certification of the State Food and Drug Administration, and is applying for the European Pharmacopoeia certificate. At present, the annual output of pharmaceutical grade isoleucine, valine and lysine acetate ranks the forefront in China.

Carbocisteine

CAS NO. ：2387-59-9 Executive Standard:CP2020 Packing Specification:25kg/drum

Yichang Sanxia Proudin signed a cooperation agreement with College of Life Sciences of South-Central Minzu University

On July 21, 2022, Yichang Sanxia Proudin Bio-Pharmaceutical Co., Ltd. (Proudin for short) and College of Life Sciences of South-Central Minzu University held the signing ceremony of the "School-Enterprise Cooperation and Co-construction Agreement on the Integration of Industry and Education"

Great news! Won the honorary of "Abide by contracts and keep promises" in Yichang City

In July 2022, Yichang Sanxia Proudin Bio-Pharmaceutical Co., Ltd. was awarded the enterprise honorary of "Abide by contracts and keep promises" in the 13th (2020-2021) of Yichang market supervision administration.

Summary of "Safety Production Month" Activities in 2022

June this year is the 21st National "Safety Production Month". In order to thoroughly study and implement General Secretary Xi Jinping's important expositions on production safety, and solidly promote the three-year special rectification of production safety in the provinces, municipalities and districts

Learn from advanced representatives and be ready to shoulder responsibilities

On the afternoon of July 1, 2022, Branch Committee Yichang Sanxia Proudin Bio-Pharmaceutical Co., Ltd. of the Communist Party of China organized the company's party members and activists desiring to join the Communist Party of China to visit and study at the New Citizen Party Member and Mass Service Center in Yichang High-tech Zone.

Drill: Forestalling fire disasters

On June 22, 2022, we carried out an emergency evacuation and fire-fighting drill. 130 staffs including CEO Wang Menghua, cadres and workers from each department participated.

A new invention patent "A Process Control Method for the Preparation of Lysine Acetate" attained by Proudin

Recently, Yichang Sanxia Proudin Biopharmaceutical Co., Ltd. received the "Notice of Granting Invention Patent" from China National Intellectual Property Administration, that the invention application "A Process Control Method for the Preparation of Lysine Acetate" by our company was noticed for granted, after the registration procedures, we will receive the letter of patent.